|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 395.4 INR | -0.24% |
|
+1.54% | -14.66% |
| Mar. 19 | IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units | MT |
| Feb. 19 | IOL Chemicals Gets Nod to Export Diabetes Drug to China | MT |
IOL Chemicals and Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 22,171.1 million compared to INR 21,840.2 million a year ago. Revenue was INR 22,427.2 million compared to INR 22,160.6 million a year ago.
Net income was INR 1,391.4 million compared to INR 1,676.7 million a year ago. Basic earnings per share from continuing operations was INR 23.7 compared to INR 28.56 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.66% | 279M | |
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B |
IOL CHEMICALS AND PHARMACEUTICALS LIMITED 
